Holy Stone Healthcare Co., Ltd. (TPEX:4194)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
8.09
+0.59 (7.87%)
Apr 29, 2026, 1:58 PM CST
6.59%
Market Cap 1.18B
Revenue (ttm) n/a
Net Income (ttm) -111.35M
Shares Out 145.97M
EPS (ttm) -0.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 107,812
Average Volume 203,705
Open 7.69
Previous Close 7.50
Day's Range 7.61 - 8.13
52-Week Range 5.32 - 12.65
Beta 0.69
RSI 57.63
Earnings Date May 13, 2026

About Holy Stone Healthcare

Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and sells hyaluronic acid-related therapeutic products in Taiwan. The company offers RenehaVis and SportVis, which are injectable medical devices for osteoarthritis and soft tissue injuries; TRUD, a medical device that contains a mixture of hyaluronic acid used for the treatment and prevention of ulcerative colitis in inflammatory bowel disease (IBD); and GAF, a gel for anal fissure healing. It also develops IBD98-M, an oral capsule that is in a Phase IIa trial for ulcera... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4194
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.